Live Breaking News & Updates on Starling Locke Capital

Stay updated with breaking news from Starling locke capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Jim Greenwood , Xiaoxi Wei , Drug Administration , Biotechnology Innovation Organization , Sourcex Therma Inc , X Therma Inc , Breakthrough Device , Gene Therapy , Chief Executive Officer , Starling Locke Capital , Managing Director , Congressional District , Advancing Regenerative Medicine , Turnkey Solution , Setting New Standards , Organ Transport Device , Breakthrough Device Designation , Francisco Bay Area ,

X-Therma's $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

/PRNewswire/ X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an. ....

United States , Xiaoxi Wei , Jim Greenwood , Drug Administration , Biotechnology Innovation Organization , Sourcex Therma Inc , X Therma Inc , Breakthrough Device , Gene Therapy , Chief Executive Officer , Starling Locke Capital , Managing Director , Eighth Congressional District , Advancing Regenerative Medicine , Turnkey Solution , Setting New Standards , Organ Transport Device , Breakthrough Device Designation , San Francisco Bay Area ,